Related Experiment Video

Updated: Jul 4, 2026

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
08:07

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry

Published on: July 26, 2019

Analysis of 3-phosphoinositide-dependent kinase-1 signaling and function in ES cells

Tanja Tamgüney1, Chao Zhang, Dorothea Fiedler

  • 1UCSF Cancer Research Institute, USA.

Experimental Cell Research
|June 3, 2008
PubMed

Insights

Researchers developed a new method to acutely inhibit 3-phosphoinositide-dependent kinase-1 (PDK1) activity. This technique confirmed PDK1 substrates and revealed its role in sensitizing cells to apoptosis and regulating tumor growth.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • 3-phosphoinositide-dependent kinase-1 (PDK1) is crucial for activating AGC family kinases.
  • Previous PDK1 inhibitors lacked specificity, complicating analysis of PDK1's biological roles.
  • Understanding PDK1's precise functions requires tools for transient and specific inhibition.

Purpose of the Study:

  • To develop a reliable system for acute and reversible inhibition of PDK1.
  • To identify and characterize novel PDK1 substrates and their dephosphorylation kinetics.
  • To elucidate the biological consequences of PDK1 inhibition, including effects on cell growth, apoptosis, and tumor development.

Main Methods:

  • Creation and characterization of a PDK1 L159G mutant for selective inhibitor binding.
  • Utilizing PDK1(-/-) ES cells to assess PDK1 activity restoration and inhibition.
  • Screening of novel inhibitor analogues (1-NM-PP1, 3,4-DMB-PP1) for specific PDK1 inhibition.
  • Analysis of cell growth, apoptosis, and allograft tumor growth following PDK1 inhibition.

Main Results:

  • The PDK1 L159G mutant system enabled specific and reversible inhibition of PDK1 activity.
  • Novel inhibitors 1-NM-PP1 and 3,4-DMB-PP1 confirmed known PDK1 substrates and revealed distinct dephosphorylation kinetics.
  • PDK1 inhibition did not significantly affect cell growth but sensitized cells to apoptosis.
  • Loss of PDK1 function abolished allograft tumor growth.

Conclusions:

  • A novel PDK1 inhibition system provides a powerful tool for studying PDK1 signaling.
  • PDK1 plays a critical role in promoting tumor growth and sensitizing cells to apoptotic stimuli.
  • This research opens new avenues for understanding AGC kinase regulation and developing targeted cancer therapies.

More Related Videos

Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation10:52

Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation

Published on: January 6, 2016

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening07:18

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening

Published on: May 12, 2017

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...